Leave a message
HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 18-20 | London, UK

September 18 -20, 2025 | London, UK
TERMC 2025

The amyloidogenic peptide stretch in human tau, tau306–311 is a promising injectable hydrogelator

Shubhangini Singh Verma, Speaker at Regenerative Medicine Conferences
Indian Institute of Technology Guwahati, India
Title : The amyloidogenic peptide stretch in human tau, tau306–311 is a promising injectable hydrogelator

Abstract:

A vast majority of peptide hydrogelators harbor a bulky, non-native aromatic moiety such as fluorene and naphthalene. These moieties facilitate self-assembly through stacking interactions and therefore serve as self-assembly platforms for hydrogels. Incorporation of foreign aromatic moieties, however, raises safety concerns as far as biomedical applications are concerned. The hydrogel research, therefore, has branched to another dimension to identify native or native-like short peptide stretches that could cause the gelation of biological fluids. For instance, the degradation of Fmoc-FF hydrogel causes cell death through necrosis. The following three criteria were applied to shortlist the peptides: (i) the peptide has one or more charged residues, (ii) there is at least one aromatic residue, and (iii) the peptide selfassembles through parallel β-sheet formation, preferably the in-register β-sheet. Using well-defined criteria, we identified the hexapeptide stretch from human tau, viz. tau306–311 (Ac-PHF6), as a promising injectable hydrogelator. Ac-PHF6 caused instant gelation of PBS at the concentration of 20 mM. The high quantum yield observed in ThT fluorescence assay indicated the formation of amyloid-like fibrils. Structural analysis using CD and FTIR spectroscopy confirmed the presence of β-sheet secondary structures in the saline environment. TEM images of hydrogel revealed the formation of long, straight fibrillar networks. The hydrogel demonstrated excellent biocompatibility by supporting the growth of HEK-293 cells. Additionally, it exhibited sustained release for both doxorubicin and calcein. Ac-PHF6 hydrogel stability assay shows that at least 95 % of peptide remains inside the hydrogel for up to two weeks. This is a valuable attribute of a wound-dressing material that can keep the wound moist, supporting regular cellular activity and promoting healing. Such hydrogels find applications as drug delivery vehicles, scaffolds for mammalian cell culture, wound-dressing material, etc.

Biography:

Shubhangini Singh Verma is a PhD student in IIT Guwahati, India. She has her expertise in both experimental and computational approaches. Her PhD work focuses on the development of peptide-based biocompatible hydrogels for biomedical applications. She is currently exploring short native peptides to design injectable hydrogels with promising potential in drug delivery and cell culture systems. Recently she has published a research article. In future, by integrating molecular design, characterization techniques, and in vitro evaluations, she aims to contribute to the development of next-generation biomaterials that are tunable, safe, and efficient.

Watsapp
a